Alimetry has received U.S. FDA clearance for updated reporting features within its Gastric Alimetry diagnostic platform, incorporating neural network–based signal processing and redesigned clinical metrics.
According to the company, the AI-driven update improves differentiation between true gastrointestinal signals and background noise, aiming to provide clinicians with a clearer, more reliable assessment of gastric function. The redesigned reports also feature centralized, streamlined metrics intended to support faster, at-a-glance clinical interpretation.
The clearance marks another regulatory milestone for noninvasive, AI-enabled GI diagnostics—and underscores a broader industry shift toward smarter signal processing, usability-focused design, and workflow-integrated digital platforms.